Adipiplon

DB06579InvestigationalSmall molecule

Adipiplon is an nonbenzodiazepine anxiolytic developed by Neurogen Corporation. It is known by the standardized identifier NG2-73.

Mechanism: Pharmacologically active on GABA(A) Receptor Benzodiazepine Binding Site
Curator reviewed
Primary indication: Investigated for use/treatment in insomnia and sleep disorders.Curator reviewed
Formula / weight: C₁₈H₁₈FN₇ · 351.389 g/mol (avg)
Code names: NG2-73

Resolves to

Compound

Structure

InChIKeyUAMAIHOEGLEXSV-UHFFFAOYSA-NSMILESCCCC1=C(CN2C=CN=C2C2=C(F)C=CC=N2)N=CN2N=C(C)N=C12

Targets

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

667Drug interactionsStructured to mechanism, not free text

1Clinical trialPhase, status and sponsor resolved per trial

2+ReferencesStructured and connected to the statements they support

Which drugs share a target with Adipiplon, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.